Kanako Gunji, Seiji Hoshi, Masahiro Maruya, Risa Hagino, Akifumi Onagi, Ryo Tanji et al. Complete Response to Pembrolizumab in a Case of Microsatellite Instability‐High, Castration‐Resistant Prostate Cancer With Somatic MSH2 Mutation. // IJU Case Reports. – 2026. – DOI: 10.1002/iju5.70301. – URL: https://onlinelibrary.wiley.com/doi/10.1002/iju5.70301?af=R
Kanako Gunji, Seiji Hoshi, Masahiro Maruya, Risa Hagino, Akifumi Onagi, Ryo Tanji, Junya Hata, Hidenori Akaihata, Soichiro Ogawa, & Yoshiyuki Kojima (2026). Complete Response to Pembrolizumab in a Case of Microsatellite Instability‐High, Castration‐Resistant Prostate Cancer With Somatic MSH2 Mutation. IJU Case Reports. https://doi.org/10.1002/iju5.70301
Kanako Gunji, et al. “Complete Response to Pembrolizumab in a Case of Microsatellite Instability‐High, Castration‐Resistant Prostate Cancer With Somatic MSH2 Mutation.” IJU Case Reports, 2026. doi:10.1002/iju5.70301.
@article{Gunji2026,
title = {Complete Response to Pembrolizumab in a Case of Microsatellite Instability‐High, Castration‐Resistant Prostate Cancer With Somatic MSH2 Mutation},
author = {Gunji, Kanako and Hoshi, Seiji and Maruya, Masahiro and Hagino, Risa and Onagi, Akifumi and Tanji, Ryo and Hata, Junya and Akaihata, Hidenori and Ogawa, Soichiro and Kojima, Yoshiyuki},
journal = {IJU Case Reports},
year = {2026},
doi = {10.1002/iju5.70301},
url = {https://onlinelibrary.wiley.com/doi/10.1002/iju5.70301?af=R}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...